Likely Exacerbation of Psychological Disorders from Covid-19 Response

por Zolnikov, Tara Rava, Clark, Tanya, Zolnikov, Tessa
Publicado 2021

Impact on direct and indirect costs of switching patients with inflammatory bowel disease from intravenous to subcutaneous infliximab (CT-P13)

por Carbery, Isabel, Burdge, Gemma, Clark, Tanya, Broglio, Giacomo, Greer, Dan, Alakkari, Alaa, Selinger, Christian Philipp
Publicado 2023

A propensity score‐matched, real‐world comparison of ustekinumab vs vedolizumab as a second‐line treatment for Crohn’s disease. The Cross Pennine study II

por Lenti, Marco Vincenzo, Dolby, Vivien, Clark, Tanya, Hall, Veronica, Tattersall, Suzanne, Fairhurst, Francesca, Kenneth, Catherine, Walker, Rachael, Kemp, Karen, Borg‐Bartolo, Simon, Limdi, Jimmy K., Taylor, Jo, Townsend, Tristan, Subramanian, Sree, Storey, Daniel, Assadsangabi, Arash, Stansfield, Catherine, Smith, Paul, Byrne, Debra, De Silvestri, Annalisa, Selinger, Christian P.
Publicado 2021